Table 1 Patient characteristics UPN .... | American Society of Hematology

Table 1

Patient characteristics

UPN	PNH type	TE		Tx/year		Hb		ARC		LDH		T bili
UPN	PNH type	Before	During	Before	During	Before	During	Before	During	Before	During	Before	During
3	AA-PNH	BC, DVT	No	6	0	8.9	10.2	123	102	4000	397	45	17
11	C-PNH	BC	No	6	0	6	12.5	200	147	1500	478	40	20.2
18	C-PNH	No	No	1	0	9.9	11.1	80	121	2108	411	11	17
5	AA-PNH	BC	No	4	0	8.9	11.4	130	158	1765	487	12	19
20	C-PNH	DVT, PE	No	2	0	10.2	10.6	95	78	2439	571	9	13.8
9	AA-PNH	No	No	12	0	8.7	11.6	241	246	3000	353	25	11.3
13	C-PNH	No	DVT	0	0	9.2	9.9	73	95	3000	492	30	23
10	AA-PNH	No	No	6	0	7.2	9.3	33	195	2000	354	62	30.2
2	C-PNH	No	No	6	0	7	10.9	200	282	2500	623	45	26.4
12	Int-PNH	No	No	6	0	8	9.9	172	191	1000	467	21	36.1
14	C-PNH	No	No	2	0	8.5	10.1	150	102	3500	450	21	13.9
16	C-PNH	No	No	6	0	8.5	8.9	200	257	2100	421	11	33
17	C-PNH	MVT	No	6	0	9	9.9	150	139	3553	553	12	10.8
8	C-PNH	DVT	No	4	0	8.3	9.6	250	184	3700	565	9.7	17.9
22	AA-PNH	BC	No	6	0	9	10	170	202	800	299	8	71
21	AA-PNH	No	No	1	0	9.1	9.6	85	52	1925	621	12.8	11.9
1	C-PNH	No	DVT	12	0.8	7.5	8.8	160	145	1500	453	24	21.8
4	C-PNH	BC	No	6	0.6	7	10.2	150	120	2000	465	25	17.3
7	AA-PNH	No	No	36	0.8	5.9	9.7	350	240	2100	362	20	15.5
15	C-PNH	No	No	12	0.8	10.6	10.2	205	235	3000	515	16	17.4
19	C-PNH	DVT, PE	No	6	5.8	5	8.7	160	161	2000	507	10	16.7
6	C-PNH	No	No	8	1.1	7.7	8.2	175	352	1000	865	9	27

UPN	PNH type	TE		Tx/year		Hb		ARC		LDH		T bili
UPN	PNH type	Before	During	Before	During	Before	During	Before	During	Before	During	Before	During
3	AA-PNH	BC, DVT	No	6	0	8.9	10.2	123	102	4000	397	45	17
11	C-PNH	BC	No	6	0	6	12.5	200	147	1500	478	40	20.2
18	C-PNH	No	No	1	0	9.9	11.1	80	121	2108	411	11	17
5	AA-PNH	BC	No	4	0	8.9	11.4	130	158	1765	487	12	19
20	C-PNH	DVT, PE	No	2	0	10.2	10.6	95	78	2439	571	9	13.8
9	AA-PNH	No	No	12	0	8.7	11.6	241	246	3000	353	25	11.3
13	C-PNH	No	DVT	0	0	9.2	9.9	73	95	3000	492	30	23
10	AA-PNH	No	No	6	0	7.2	9.3	33	195	2000	354	62	30.2
2	C-PNH	No	No	6	0	7	10.9	200	282	2500	623	45	26.4
12	Int-PNH	No	No	6	0	8	9.9	172	191	1000	467	21	36.1
14	C-PNH	No	No	2	0	8.5	10.1	150	102	3500	450	21	13.9
16	C-PNH	No	No	6	0	8.5	8.9	200	257	2100	421	11	33
17	C-PNH	MVT	No	6	0	9	9.9	150	139	3553	553	12	10.8
8	C-PNH	DVT	No	4	0	8.3	9.6	250	184	3700	565	9.7	17.9
22	AA-PNH	BC	No	6	0	9	10	170	202	800	299	8	71
21	AA-PNH	No	No	1	0	9.1	9.6	85	52	1925	621	12.8	11.9
1	C-PNH	No	DVT	12	0.8	7.5	8.8	160	145	1500	453	24	21.8
4	C-PNH	BC	No	6	0.6	7	10.2	150	120	2000	465	25	17.3
7	AA-PNH	No	No	36	0.8	5.9	9.7	350	240	2100	362	20	15.5
15	C-PNH	No	No	12	0.8	10.6	10.2	205	235	3000	515	16	17.4
19	C-PNH	DVT, PE	No	6	5.8	5	8.7	160	161	2000	507	10	16.7
6	C-PNH	No	No	8	1.1	7.7	8.2	175	352	1000	865	9	27

AA-PNH, aplastic anemia-PNH; ARC, absolute reticulocyte count (×10⁹); BC, Budd-Chiari syndrome; C-PNH, classic PNH; DVT, deep vein thrombosis; Hb, hemoglobin level; Int-PNH, intermediate PNH; MVT, mesenteric vein thrombosis; PE, pulmonary embolism; T bili, unfractionated bilirubin (μM/L); TE, thromboembolic events; Tx/year, number of packed red blood cell units transfused in the last year (before) or in 1 year during eculizumab treatment (during); UPN, unique patient number.

View Large

This Feature Is Available To Subscribers Only